Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Peptides|November 19, 2005
Effect of MELANOTAN, [Nle(4), D-Phe(7)]-alpha-MSH, on melanin synthesis in humans with MC1R variant allelesLiesel M Fitzgerald, Jayne L Fryer, Terence Dwyer, et al.
Cancer Medicine|August 5, 2025
Socioeconomic and Geographic Disparities in Anorectal and Urinary Procedures Following Radiotherapy for Prostate CancerTenaw Tiruye, Braden Higgs, Michael O'Callaghan, et al.
Cancer Epidemiology|November 4, 2024
Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancerTenaw Tiruye, David Roder, Liesel M FitzGerald, et al.
International Urology and Nephrology|July 25, 2025
Post-prostatectomy rehospitalisation rates and risk factors in South Australian men with prostate cancer: evidence from linked dataTenaw Tiruye, Alex Jay, Michael O'Callaghan, et al.
Cancer Epidemiology|December 23, 2023
Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancerTenaw Tiruye, David Roder, Liesel M FitzGerald, et al.
Journal of Diabetes Research|December 4, 2020
Identifying Genetic Risk Factors for Diabetic Macular Edema and the Response to TreatmentRajya L Gurung, Liesel M FitzGerald, Bennet J McComish, et al.
Genes|August 11, 2019
Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to ImplementationReka Varnai, Leena M Koskinen, Laura E Mäntylä, et al.
Diabetes|December 12, 2002
Evidence for a novel type 1 diabetes susceptibility locus on chromosome 8Michèle M Sale, Liesel M FitzGerald, Jacinta C Charlesworth, et al.
The Prostate|May 27, 2024
Impact of comorbidities on prostate cancer-specific mortality: A population-based cohort studyTenaw Tiruye, David Roder, Liesel M FitzGerald, et al.
Pageof 9